awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45958620-39427D35-8782-4268-A627-E5EEAEEA40B0
Q45958620-39427D35-8782-4268-A627-E5EEAEEA40B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45958620-39427D35-8782-4268-A627-E5EEAEEA40B0
Part I: Checkpoint inhibitors in cancer therapy.
P2860
Q45958620-39427D35-8782-4268-A627-E5EEAEEA40B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45958620-39427D35-8782-4268-A627-E5EEAEEA40B0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d2fffd2a83e9fad24dbe45e11c7c84bcbbe4fb4a
P2860
Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab.